The Biotechnology Calendar, Inc. BioResearch Product Faire™ will be returning to Washington University, St. Louis for its 19th Annual event. WashU's Life Science R&D Expenditures and NIH funding has been totaling about $1 Billion the past few years proving the University's dedication to being at the forefront of life science research and providing a prime opportunity for boosting scientific sales.
Read MoreRecent Posts
0 Comments Click here to read/write comments
Tags: Washington University St. Louis, Washington University, WashU, MO, St Louis, 2018
Join Biotechnology Calendar, Inc. at the January Texas Medical Center BioResearch Product Faire Event and exhibit at the largest medical complex in the world.
With life science expenditures and NIH funding totaling more than 2.2 billion dollars , the BioResearch Product Faire™ offers an excellent opportunity to meet with well-funded researchers. This is further supported by consistent attendance at these trade shows well in excess of 400 researcher attendees, occasionally breaking 500 researchers in attendance.
Texas Medical Center has a new state of the art medical campus under construction which is estimated for completion in 2019 while the Zayed Building at MD Anderson just opend been opened in 2016. We invite you to join us early next year for Houston’s 18th Annual BioResearch Product Faire™.
Read More
0 Comments Click here to read/write comments
Tags: cancer research, Texas Medical Center, Texas, tmc, Houston, Lab Product Sales, 2018
In late September the National Science Foundation awarded the University of Pennsylvania a five-year grant of $24 million to create a Mechanobiology Center, as posted on the university website. This grant is in coincidence with three other large grants to fund establishing four Science and Technology Centers (STC) totaling $94 Million; the other three STC’s being the Center for Bright Beams at Cornell University, the Center for Cellular Construction at UC San Francisco, and the Center on Real-Time Functional Imaging at UC Boulder.
Read More
0 Comments Click here to read/write comments
Tags: Pennsylvania, University of Pennsylvania, UPenn, Philadelphia, new funding, New research center, 2017
Researchers from UCLA and partnering schools guided by Laurent Bentolila found evidence supporting the spread of malignant cells through angiotropism with vascular co-option, and even suggested they may be related or identical processes. These findings were published in Nature Scientific Reports. With angiotropism being the ability for cells to travel along surface of blood vessels, but not be inside of them, also called extravascular migratory metastasis (EVMM) and vascular co-option being the ability for a tumor to use a blood supply and travel along it, this means cancer has an outlet to spread outside of the bloodstream. The spread outside of the bloodstream means some current methods of treating cancer would be ineffective.
“... if the metastasizing cells are on the outside of the blood vessels, they escape exposure to the treatment and continue to spread cancer.”
-Laurent A. Bentolila
Read More
0 Comments Click here to read/write comments
Tags: CA, University of California Los Angeles, cancer research, Los Angeles, Cancer, LAVS, UCLA, laboratory, lab products, 2016
In 2014, the Wisconsin Alzheimer's Disease Research Center received a five-year grant from the NIH totalling $7.5M dollars. The center was the first of its kind, created in 2009, and has provided a focused place of research on Alzheimer's diagnosis and treatment. With funding through March of 2019, the center is moving forward, with one recent publication indicating a panel of biomarkers that have been linked with Alzheimer's.
Read More
0 Comments Click here to read/write comments
Tags: Wisconsin, University of Wisconsin, University of Wisconsin Madison, UWisc, Alzheimer's Research, Alzheimer's, Madison, 2016